There is no question that there is abundant PDE5 expression in the pulmonary vasculature [28,30,39], and for patients with pulmonary hypertension, inhibition of PDE5 will decrease PASP [39–42]. This evidence concerns the gene PDE5A and pulmonary hypertension.